Care este prețul pentru BetterLife Pharma Inc. (BETR)

Prețul pentru BetterLife Pharma Inc. (BETR) este $0.24953854

Care este capitalizarea de piață pentru BetterLife Pharma Inc. (BETR)

Capitalizarea de piață pentru BetterLife Pharma Inc. (BETR) este $40.40M

BetterLife Pharma Inc. (BETR) Preț și Capitalizare de Piață

BetterLife Pharma Inc. is a biotechnology company focused on the global development and commercialization of therapeutic compounds, particularly for neurological disorders. The firm also innovates drug candidates utilizing complementary interferon-based technologies, designed to engage the immune system in combating viral infections. Its active development pipeline includes BETR-001, intended for major depressive disorder, treatment-resistant depression, cluster headaches, and post-traumatic stress disorder. Another key asset, BETR-002, is being advanced to address benzodiazepine dependency, anxiety, and spasticity. Further in development are MM-003 for COVID-19 and other respiratory viral infections; MM-001, a topical intravaginal cream for HPV-induced cervical intraepithelial neoplasia; and AP-002, designated for cancer treatment. BetterLife Pharma Inc. maintains a research collaboration with the University of California San Diego, focusing on preclinical behavioral pharmacology studies of TD-0148A, a lysergic acid diethylamide derivative solution. Headquartered in Vancouver, Canada, the company was founded in 2002 and was formerly known as Pivot Pharmaceuticals Inc. before adopting the name BetterLife Pharma Inc. in December 2019.

Prețul pentru BETR	Activul B	Capitalizarea de piață a B	Rezultate
$32,380.06 $40.40M	NVDA	$5.242T	+12,975,875.02%
$28,725.65 $40.40M	AAPL	$4.650T	+11,511,410.23%
$25,394.47 $40.40M	GOOG	$4.111T	+10,176,473.89%
$22,099.92 $40.40M	MSFT	$3.578T	+8,856,215.13%
$17,369.56 $40.40M	AMZN	$2.812T	+6,960,573.98%

Prețul pentru BETR

Activul B

Capitalizarea de piață a B

Rezultate

$32,380.06 $40.40M